NCOA3 and metastatic neoplasm: Moreover, genome-wide analysis of transcriptionally activating H3K4me3 mark in endocrine resistant metastatic tumors by ChIP-seq [16] (n = 10) revealed enhanced activity at AIB1 loci in bad outcome versus good outcome metastatic tumors (Fig. S1E).